改善药物坚持和改变生活方式:为心力衰竭患者提供基于图像的教育工具
Lingyan Gao1, Qing Xie1, Tiantian Liu1
1Department of Pharmacy, Aerospace Center Hospital, Beijing, People's Republic of China.
Patient preference and adherence
|August 5, 2025
概括
一个新的基于图像的工具改善了患者的心力衰竭 (HF) 的知识. 它与患者和专业人员一起开发,增强对治疗的理解和坚持.
科学领域:
- 心脏病学 心脏病学
- 卫生识字 卫生识字
- 患者教育 患者教育
背景情况:
- 在心力衰竭 (HF) 患者中,低的疾病特异性知识与治疗方案和建议的不良遵守有关.
- 健康素养有限的个人尤其受到现有的教育工具不足的影响.
- 对HF患者进行可访问和有效的教育干预措施至关重要.
研究的目的:
- 开发一个创新的教育工具,旨在增强心力衰竭 (HF) 的知识.
- 创建一种更容易获得和有效的方法,用于患者在高频管理方面的教育.
主要方法:
- 一个基于图像的教育工具是由医疗保健专业人员和HF患者共同开发的.
- 健康信念模型 (HBM) 指导了开发过程,结合了定性和定量方法.
- 通过焦点小组,文献评论和患者反问卷进行了代的改进.
主要成果:
- 最终的工具包括七个A3大小的图像,并附有涵盖关键HF主题的文本.
- 参与者的反表明了高准确度,可读性,可用性和整体满意度 (≥4.5/5 利克尔特尺度).
- 该工具涉及HF认知,原因,预防,治疗和自我管理,包括支持主题.
结论:
- 这种基于图像的HBM信息工具有效地解决了HF患者的教育需求.
- 该工具在准确性,可读性,可用性和满意度方面表现出很高的表现.
- 这种教育干预有可能改善患者遵守药理和非药理HF管理策略.
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: β-Blockers
435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure Drugs: Inotropic Agents
724
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
724


